COMT inhibitors, meant to boost Parkinson’s treatment, unintentionally promote gut bacteria that break down levodopa. This microbiome-mediated interaction hinders the drug's effectiveness.

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Professor Jaewon Ko’s research group has found the mechanism by which a MDGA1 gene mutation induces autism symptoms only in male mice. - Restoring broken brain circuits with female hormone modulating ...

ROCKVILLE, Md., April 9, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant's dosing following the clearance of the Investigational ...

A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new ...

Visceral fat, which is stored around your stomach, can be especially hard to lose. But implementing certain foods into your ...

The etiology of liver cirrhosis has transformed from hepatitis B virus-driven to metabolic dysfunction-associated steatotic ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

Vitamin D supplementation is linked to less disease activity and inflammation in inflammatory bowel disease and may restore ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

A fungus that can wipe out up to 50% of a sugar beet crop may soon meet its match in a new generation of smart disease ...

Multifactorial diseases pose a significant global health challenge, impacting economically developed nations with conditions ...